Cellyan Biotechnology Co., Ltd (HKPD) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Cellyan Biotechnology Co., Ltd (HKPD) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $5.9M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 2.63 to the broader market. Cellyan Biotechnology Co. Led by Chenyu Liang, public since 2025-01-15.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for HKPD as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →